atorvastatin has been researched along with Cerebral Hemorrhage in 35 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 13 (37.14) | 29.6817 |
| 2010's | 15 (42.86) | 24.3611 |
| 2020's | 7 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, C; Chen, D; Guan, J; Liu, S; Sui, L; Sun, X | 1 |
| Li, X; Yang, Q; Yang, Y | 1 |
| Chen, H; Hu, Y; Qin, X; Wang, M; Wang, S; Wu, J; Wu, T; Wu, Y; Yang, R; Yu, H | 1 |
| Chen, K; Lan, S; Liao, G; Luo, H; Xie, Z; Xu, J; Xu, S; Yang, X | 1 |
| Chen, WF; He, SP; Hong, MP; Kang, TS; Wu, JH; Yang, QW | 1 |
| Gong, X; Li, J; Lou, M; Luo, Z; Sun, J; Yan, S; Zhao, Y; Zhou, H; Zhou, Y | 1 |
| Spence, JD | 1 |
| Hoi, MPM; Huang, B; Huang, XH; Lee, SMY; Li, S; Tang, JY; Zhou, ZY | 1 |
| Auger, F; Barus, R; Bergeron, S; Bordet, R; Chen, Y; Cordonnier, C; Deguil, J; Durieux, N; Gautier, S; Pasquier, F; Potey, C; Ravasi, L; Skrobala, E | 1 |
| Jayakrishnan, C; Karadan, U; Manappallil, RG; Supreeth, RN | 1 |
| Hoi, PM; Huang, B; Huang, XH; Kwan, YW; Lee, SM; Li, S; Tang, JY; Zhou, ZY | 1 |
| Allan, SM; Badrock, AP; Barrington, J; Crilly, S; Fotiou, E; Hudson, G; Hurlstone, A; Kasher, PR; Laurie, SE; Njegic, A; Parry-Jones, AR; Rivers-Auty, J; Webb, K; Young, HL | 1 |
| Akers, AL; Awad, IA; Cao, Y; Christoforidis, GA; Fam, MD; Flemming, KD; Girard, R; Hanley, DF; Hobson, N; Koenig, JI; Koskimäki, J; Lane, K; Lee, C; Liao, JK; Lyne, SB; McBee, N; Morrison, L; Piedad, K; Polster, SP; Shenkar, R; Sorrentino, M; Stadnik, A; Thompson, RE; Whitehead, KJ; Zeineddine, HA | 1 |
| Hou, T; Lee, SM; Li, P; Li, S; Li, Y; Pan, P; Shen, M; Yu, H; Zhang, L; Zhou, S | 1 |
| Dippel, DW; Scheele, M; van den Meiracker, AH; Versmissen, J | 1 |
| Chen, Y; Geng, J; Li, Y; Lin, Y; Mu, Z; Pan, Y; Shi, G; Song, Y; Sun, Y; Xu, Q; Yang, GY; Yu, L | 1 |
| Hou, T; Lee, SM; Li, C; Li, D; Li, Y; Pan, P; Shen, M; Sun, H; Tian, S; Zhou, H | 1 |
| Fatar, M; Grudzenski, S; Heiler, P; Hennerici, MG; Reuter, B; Schad, L; Staufenbiel, M; Venus, A | 1 |
| Fitchett, DH; Goodman, SG; Langer, A | 1 |
| Amarenco, P; Callahan, A; Goldstein, LB; Hennerici, MG; Messig, M; Sillesen, H; Welch, KM; Zivin, J | 1 |
| Amarenco, P; Benavente, O; Callahan, A; Gilbert, S; Goldstein, LB; Hennerici, MG; Rudolph, AE; Sillesen, H; Simunovic, L; Welch, KM; Zivin, JA | 1 |
| Goldstein, MR; Mascitelli, L; Pezzetta, F | 1 |
| El-Remessy, AB; Elewa, HF; Ergul, A; Fagan, SC; Frye, RF; Johnson, MH; Kozak, A | 1 |
| Chaturvedi, S; Goldstein, MR; Mascitelli, L; Pezzetta, F | 1 |
| Chopp, M; Han, Y; Karki, K; Knight, RA; Ledbetter, KA; Seyfried, DM; Yang, D; Zhang, J | 1 |
| Chopp, M; Ding, C; Han, Y; Karki, K; Knight, RA; Seyfried, DM; Yang, D; Zhang, J | 1 |
| Cui, JJ; Gao, F; Li, YR; Wang, D | 1 |
| Chaogang, T; Ewen, T; Guanghong, X; Jun, W; Liming, T; Qiuting, L; Tao, T | 1 |
| Eisa-Beygi, S; Ekker, M; Hatch, G; Moon, TW; Noble, S | 1 |
| Alexy, T; Czopf, J; Habon, T; Horvath, B; Juricskay, I; Kesmarky, G; Koltai, K; Marton, Z; Szapary, L; Szots, M; Toth, K | 1 |
| Chu, K; Han, SY; Jeong, SW; Jung, KH; Kim, JY; Kim, M; Lee, ST; Roh, JK | 1 |
| Bydon, A; Chen, J; Chopp, M; Han, Y; Lu, D; Seyfried, D | 1 |
| Amarenco, P; Bogousslavsky, J; Callahan, A; Goldstein, LB; Hennerici, M; Rudolph, AE; Sillesen, H; Simunovic, L; Szarek, M; Welch, KM; Zivin, JA | 1 |
| Cohen, JS | 1 |
| Karam, JG; Loney-Hutchinson, L; McFarlane, SI | 1 |
1 review(s) available for atorvastatin and Cerebral Hemorrhage
| Article | Year |
|---|---|
[Statins after intracerebral haemorrhage: is this safe?].
Topics: Atorvastatin; Cerebral Hemorrhage; Cholesterol; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Stroke | 2015 |
3 trial(s) available for atorvastatin and Cerebral Hemorrhage
| Article | Year |
|---|---|
Atorvastatin Treatment of Cavernous Angiomas with Symptomatic Hemorrhage Exploratory Proof of Concept (AT CASH EPOC) Trial.
Topics: Atorvastatin; Cerebral Hemorrhage; Double-Blind Method; Female; Follow-Up Studies; Hemangioma, Cavernous; Hemangioma, Cavernous, Central Nervous System; Humans; Magnetic Resonance Imaging; Male; Proof of Concept Study; Prospective Studies; Protein Kinase Inhibitors; rhoA GTP-Binding Protein; Treatment Outcome | 2019 |
Results of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial by stroke subtypes.
Topics: Anticholesteremic Agents; Atorvastatin; Brain Ischemia; Cerebral Hemorrhage; Female; Heptanoic Acids; Humans; Hypercholesterolemia; Male; Middle Aged; Placebos; Proportional Hazards Models; Pyrroles; Risk Factors; Stroke; Treatment Outcome | 2009 |
High-dose atorvastatin after stroke or transient ischemic attack.
Topics: Adult; Atorvastatin; Cardiovascular Diseases; Cerebral Hemorrhage; Cerebral Infarction; Cholesterol, LDL; Drug Therapy, Combination; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ischemic Attack, Transient; Male; Proportional Hazards Models; Pyrroles; Risk; Secondary Prevention; Stroke | 2006 |
31 other study(ies) available for atorvastatin and Cerebral Hemorrhage
| Article | Year |
|---|---|
Atorvastatin suppresses NLRP3 inflammasome activation in intracerebral hemorrhage via TLR4- and MyD88-dependent pathways.
Topics: Animals; Atorvastatin; Cerebral Hemorrhage; Cytokines; Gene Expression Regulation; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Male; Mice; Mice, Inbred C57BL; Myeloid Differentiation Factor 88; Neurons; NLR Family, Pyrin Domain-Containing 3 Protein; Signal Transduction; Toll-Like Receptor 4 | 2022 |
Related Factors of Cerebral Hemorrhage after Cerebral Infarction and the Effect of Atorvastatin Combined with Intensive Nursing Care.
Topics: Adult; Atorvastatin; Atrial Fibrillation; Case-Control Studies; Cerebral Hemorrhage; Cerebral Infarction; Humans; Hypertension; Retrospective Studies; Stroke; Tablets | 2022 |
Is statin therapy after ischaemic stroke associated with increased intracerebral hemorrhage? The association may be dependent on intensity of statin therapy.
Topics: Atorvastatin; Brain Ischemia; Cerebral Hemorrhage; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ischemic Stroke; Rosuvastatin Calcium; Simvastatin; Stroke | 2023 |
The L-shaped correlation between systolic blood pressure and short-term and long-term mortality in patients with cerebral hemorrhage.
Topics: Atorvastatin; Blood Pressure; Cefdinir; Cerebral Hemorrhage; Cerebral Infarction; Humans; Hypertension; Hypotension | 2023 |
Correlation between lipid-lowering therapy and cerebral microbleeds.
Topics: Atorvastatin; Cerebral Hemorrhage; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Magnetic Resonance Imaging; Retrospective Studies; Risk Factors; Rosuvastatin Calcium | 2023 |
Low-density lipoprotein cholesterol, statin therapy, and cerebral microbleeds: The CIRCLE study.
Topics: Atorvastatin; Cerebral Hemorrhage; Cerebral Small Vessel Diseases; Cholesterol, LDL; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Stroke | 2023 |
Intracerebral Hemorrhage in SPARCL: What Was the Relationship to LDL-C?
Topics: Atorvastatin; Cerebral Hemorrhage; Cholesterol, LDL; Humans; Stroke | 2020 |
Tanshinone I prevents atorvastatin-induced cerebral hemorrhage in zebrafish and stabilizes endothelial cell-cell adhesion by inhibiting VE-cadherin internalization and actin-myosin contractility.
Topics: Abietanes; Actins; Animals; Animals, Genetically Modified; Antigens, CD; Atorvastatin; Cadherins; Cell Adhesion; Cerebral Hemorrhage; Embryo, Nonmammalian; Human Umbilical Vein Endothelial Cells; Humans; Myosins; Protective Agents; Zebrafish | 2018 |
Role of cortical microbleeds in cognitive impairment: In vivo behavioral and imaging characterization of a novel murine model.
Topics: Animals; Atorvastatin; Brain; Cerebral Hemorrhage; Cognitive Dysfunction; Collagenases; Disease Models, Animal; Male; Mice; Positron Emission Tomography Computed Tomography | 2019 |
Pontine haemorrhage disguised as Bell's palsy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Anticholesteremic Agents; Atorvastatin; Bell Palsy; Cerebral Hemorrhage; Diagnosis, Differential; Diuretics, Osmotic; Facial Paralysis; Humans; Magnetic Resonance Imaging; Male; Mannitol; Middle Aged; Neural Pathways; Perindopril; Physical Therapy Modalities; Pons; Treatment Outcome | 2018 |
Sodium tanshinone IIA sulfonate promotes endothelial integrity via regulating VE-cadherin dynamics and RhoA/ROCK-mediated cellular contractility and prevents atorvastatin-induced intracerebral hemorrhage in zebrafish.
Topics: Animals; Animals, Genetically Modified; Antigens, CD; Atorvastatin; Cadherins; Cell Survival; Cerebral Hemorrhage; Dose-Response Relationship, Drug; Endothelium, Vascular; Human Umbilical Vein Endothelial Cells; Humans; Phenanthrenes; rho-Associated Kinases; rhoA GTP-Binding Protein; Zebrafish | 2018 |
Using zebrafish larval models to study brain injury, locomotor and neuroinflammatory outcomes following intracerebral haemorrhage.
Topics: Animals; Atorvastatin; Brain; Brain Injuries; Cerebral Hemorrhage; Disease Models, Animal; Immunity, Innate; Inflammation; Larva; Locomotion; Macrophage Activation; Mutation; Phagocytosis; Phenotype; Zebrafish | 2018 |
Discovery of Rho-kinase inhibitors by docking-based virtual screening.
Topics: Animals; Antineoplastic Agents; Atorvastatin; Breast Neoplasms; Cell Line, Tumor; Cerebral Hemorrhage; Drug Evaluation, Preclinical; Drug Screening Assays, Antitumor; Female; HeLa Cells; Heptanoic Acids; Humans; Lung Neoplasms; Models, Molecular; Molecular Docking Simulation; Molecular Dynamics Simulation; Molecular Structure; Multiple Myeloma; Protein Kinase Inhibitors; Pyrroles; rho-Associated Kinases; Zebrafish | 2013 |
Early Use of Statin in Patients Treated with Alteplase for Acute Ischemic Stroke.
Topics: Aged; Atorvastatin; Brain Ischemia; Cerebral Hemorrhage; Early Medical Intervention; Female; Fibrinolytic Agents; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Risk Factors; Stroke; Thrombolytic Therapy; Time Factors; Tissue Plasminogen Activator; Treatment Outcome | 2016 |
Discovery of Novel ROCK1 Inhibitors via Integrated Virtual Screening Strategy and Bioassays.
Topics: Actin Depolymerizing Factors; Amides; Animals; Atorvastatin; Binding Sites; Cerebral Hemorrhage; Databases, Chemical; Databases, Protein; Disease Models, Animal; Enzyme Activation; Human Umbilical Vein Endothelial Cells; Humans; Inhibitory Concentration 50; Molecular Docking Simulation; Phosphorylation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Pyridines; Pyrroles; rho-Associated Kinases; Signal Transduction; Structure-Activity Relationship; Zebrafish | 2015 |
Statin Therapy and the Development of Cerebral Amyloid Angiopathy--A Rodent in Vivo Approach.
Topics: Amyloid beta-Protein Precursor; Animals; Anticholesteremic Agents; Atorvastatin; Cerebral Amyloid Angiopathy; Cerebral Hemorrhage; Disease Models, Animal; Gene Expression; Magnetic Resonance Imaging; Mice; Mice, Inbred C57BL; Mice, Transgenic | 2016 |
Ischemic stroke: a cardiovascular risk equivalent? Lessons learned from the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial.
Topics: Atorvastatin; Cardiovascular Diseases; Cerebral Hemorrhage; Cholesterol; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ischemic Attack, Transient; Pyrroles; Randomized Controlled Trials as Topic; Secondary Prevention; Stroke | 2008 |
Atorvastatin reduces the risk of cardiovascular events in patients with carotid atherosclerosis: a secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial.
Topics: Aged; Atorvastatin; Brain Ischemia; Carotid Stenosis; Cerebral Hemorrhage; Cholesterol, LDL; Coronary Disease; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Ischemic Attack, Transient; Male; Middle Aged; Pyrroles; Randomized Controlled Trials as Topic; Recurrence; Risk; Treatment Outcome | 2008 |
Hemorrhagic stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels study.
Topics: Age Factors; Aged; Atorvastatin; Causality; Cerebral Hemorrhage; Clinical Trials as Topic; Dose-Response Relationship, Drug; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypertension; Iatrogenic Disease; Intracranial Arteriosclerosis; Male; Pyrroles; Sex Factors | 2009 |
Early atorvastatin reduces hemorrhage after acute cerebral ischemia in diabetic rats.
Topics: Acute Disease; Animals; Atorvastatin; Brain Ischemia; Cerebral Hemorrhage; Diabetes Mellitus, Type 2; Drug Administration Schedule; Heptanoic Acids; Male; Pyrroles; Rats; Rats, Wistar; Time Factors | 2009 |
Effect of atorvastatin in elderly patients with a recent stroke or transient ischemic attack.
Topics: Age Distribution; Age Factors; Aged; Anticholesteremic Agents; Atorvastatin; Cerebral Hemorrhage; Cholesterol, LDL; Clinical Trials as Topic; Heptanoic Acids; Humans; Iatrogenic Disease; Ischemic Attack, Transient; Pyrroles; Risk Assessment; Risk Factors; Stroke | 2009 |
Simvastatin and atorvastatin improve neurological outcome after experimental intracerebral hemorrhage.
Topics: Animals; Apoptosis; Atorvastatin; Biomarkers; Brain; Brain Infarction; Bromodeoxyuridine; Cerebral Hemorrhage; Cytoprotection; Diffusion Magnetic Resonance Imaging; Disease Models, Animal; Doublecortin Domain Proteins; Doublecortin Protein; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Microtubule-Associated Proteins; Nerve Degeneration; Neurogenesis; Neuronal Plasticity; Neuropeptides; Neuroprotective Agents; Pyrroles; Rats; Rats, Wistar; Regeneration; Simvastatin; Treatment Outcome | 2009 |
Vascular recovery promoted by atorvastatin and simvastatin after experimental intracerebral hemorrhage: magnetic resonance imaging and histological study.
Topics: Animals; Atorvastatin; Blood-Brain Barrier; Brain Edema; Cerebral Hemorrhage; Cerebrovascular Circulation; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunohistochemistry; Magnetic Resonance Imaging; Neovascularization, Physiologic; Nerve Regeneration; Pyrroles; Rats; Rats, Wistar; Simvastatin | 2011 |
Effects of atorvastatin on pathological changes in brain tissue and plasma MMP-9 in rats with intracerebral hemorrhage.
Topics: Animals; Atorvastatin; Brain; Brain Edema; Cerebral Hemorrhage; Disease Models, Animal; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Matrix Metalloproteinase 9; Neuroprotective Agents; Pyrroles; Rats; Rats, Wistar; Water | 2012 |
Neuroprotective effect of atorvastatin involves suppression of TNF-α and upregulation of IL-10 in a rat model of intracerebral hemorrhage.
Topics: Animals; Atorvastatin; Behavior, Animal; Brain Edema; Cerebral Hemorrhage; Disease Models, Animal; Heptanoic Acids; Interleukin-10; Male; Microglia; Neuroprotective Agents; Pyrroles; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha; Up-Regulation | 2013 |
The 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR) pathway regulates developmental cerebral-vascular stability via prenylation-dependent signalling pathway.
Topics: Alkyl and Aryl Transferases; Animals; Atorvastatin; cdc42 GTP-Binding Protein; Cerebral Hemorrhage; Cerebrum; Embryo, Nonmammalian; Endothelial Cells; Heptanoic Acids; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mice; Morpholinos; Polyisoprenyl Phosphates; Prenylation; Pyrroles; rhoA GTP-Binding Protein; Signal Transduction; Zebrafish | 2013 |
Short-term effect of low-dose atorvastatin on haemorrheological parameters, platelet aggregation and endothelial function in patients with cerebrovascular disease and hyperlipidaemia.
Topics: Aged; Atorvastatin; Cerebral Hemorrhage; Cerebrovascular Disorders; Endothelium, Vascular; Female; Heptanoic Acids; Humans; Hyperlipidemias; Male; Middle Aged; Platelet Aggregation; Pyrroles; Time Factors | 2004 |
HMG-CoA reductase inhibitor, atorvastatin, promotes sensorimotor recovery, suppressing acute inflammatory reaction after experimental intracerebral hemorrhage.
Topics: Animals; Anti-Inflammatory Agents; Atorvastatin; Atrophy; Brain; Cell Death; Cerebral Hemorrhage; Hematoma; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Models, Animal; Neuroprotective Agents; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Psychomotor Performance; Pyrroles; Rats; Rats, Sprague-Dawley | 2004 |
Improvement in neurological outcome after administration of atorvastatin following experimental intracerebral hemorrhage in rats.
Topics: Animals; Atorvastatin; Brain; Cerebral Hemorrhage; Disease Models, Animal; Dose-Response Relationship, Drug; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Nervous System; Pyrroles; Rats; Rats, Wistar; Recovery of Function; Severity of Illness Index; Treatment Outcome | 2004 |
Statin therapy after stroke or transient ischemic attack.
Topics: Atorvastatin; Cardiovascular Diseases; Cerebral Hemorrhage; Cholesterol, LDL; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pyrroles; Risk Factors; Stroke; Transaminases | 2006 |
High-dose atorvastatin after stroke or transient ischemic attack: The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators.
Topics: Adult; Atorvastatin; Cardiovascular Diseases; Cerebral Hemorrhage; Cerebral Infarction; Cholesterol, LDL; Drug Therapy, Combination; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ischemic Attack, Transient; Male; Pyrroles; Randomized Controlled Trials as Topic; Recurrence; Risk; Stroke | 2008 |